233 related articles for article (PubMed ID: 32276015)
21. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
22. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
23. Factors Affecting Long-Term Results of Above-Knee Femoropopliteal Bypass: A Single-Center Contemporary Study.
De Santis F; Pattaro C; Mani G; Pramstaller PP; Loreni G; Martini G
Vasc Endovascular Surg; 2016 Feb; 50(2):72-9. PubMed ID: 26983664
[TBL] [Abstract][Full Text] [Related]
24. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.
Brouillet J; Deloose K; Goueffic Y; Poirier M; Midy D; Caradu C; Ducasse E
J Cardiovasc Surg (Torino); 2018 Jun; 59(3):392-404. PubMed ID: 27272981
[TBL] [Abstract][Full Text] [Related]
25. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
[TBL] [Abstract][Full Text] [Related]
26. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
[No Abstract] [Full Text] [Related]
27. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
28. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
[TBL] [Abstract][Full Text] [Related]
29. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
30. Atheromatous occlusive lesions of the popliteal artery treated with stent grafts: predictive factors of midterm patency.
Peidro J; Boufi M; Loundou Dieudonné A; Hartung O; Dona B; Vernet F; Alimi Y
Ann Vasc Surg; 2015; 29(4):708-15. PubMed ID: 25595105
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Femoropopliteal Lesions With the BioMimics 3D Vascular Stent System: Two-Year Results From the MIMICS-2 Trial.
Sullivan TM; Zeller T; Nakamura M; Gaines PA;
J Endovasc Ther; 2021 Apr; 28(2):236-245. PubMed ID: 33331207
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
[TBL] [Abstract][Full Text] [Related]
33. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
AbuRahma AF; Beasley M; AbuRahma ZT; Davis M; Adams E; Dean LS; Shapiro J; Scott G; Davis E
J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
[TBL] [Abstract][Full Text] [Related]
35. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
[TBL] [Abstract][Full Text] [Related]
36. Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.
Sarkadi H; Bérczi V; Kollár A; Kiss D; Jakabfi P; Végh EM; Nemes B; Merkely B; Hüttl K; Dósa E
Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):199-204. PubMed ID: 25579877
[TBL] [Abstract][Full Text] [Related]
37. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial.
Jahnke T; Andresen R; Müller-Hülsbeck S; Schäfer FK; Voshage G; Heller M; Brossmann J
J Vasc Interv Radiol; 2003 Jan; 14(1):41-51. PubMed ID: 12525585
[TBL] [Abstract][Full Text] [Related]
38. Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease.
Maitrias P; Deltombe G; Molin V; Reix T
J Vasc Surg; 2017 Feb; 65(2):406-413. PubMed ID: 27693029
[TBL] [Abstract][Full Text] [Related]
39. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter
Iida O; Takahara M; Soga Y; Yamaoka T; Nanto S; Kuratani T; Sakata Y; Mano T
J Endovasc Ther; 2021 Feb; 28(1):123-131. PubMed ID: 32959718
[TBL] [Abstract][Full Text] [Related]
40. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
